SCHEMBL223905

SCHEMBL223905

CCC[Si](OC)(OC)OCCCCN

nearest known ligand 0.36

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 8/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
ALDH1A1 P00352 1/20 0.36
TSHR P16473 1/20 0.36
EPHX1 P07099 1/20 0.36
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL734326 0.98 DNM1 (0.39) DNM1MEN1KMT2AALDH1A1TSHR
SCHEMBL110290 0.94 LMNA (0.32) DNM1MEN1KMT2AALDH1A1TSHR
SCHEMBL31719619 0.89 DNM1 (0.43) DNM1MEN1KMT2AALDH1A1TSHR
SCHEMBL8729872 0.88 NFKB1 (0.30)
SCHEMBL28411728 0.88 NFKB1 (0.30)
SCHEMBL6896664 0.88 NFKB1 (0.30)
SCHEMBL691752 0.86 LMNA (0.42) DNM1MEN1KMT2AALDH1A1TSHR
SCHEMBL2356022 0.86 DNM1 (0.33) DNM1MEN1KMT2AALDH1A1TSHR
SCHEMBL28858270 0.85 LMNA (0.31) LMNA
SCHEMBL28554977 0.85 LMNA (0.44) DNM1MEN1KMT2AALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2718755-B1 POLARIZING PHOTOCHROMIC ARTICLES TRANSITIONS OPTICAL INC (US) 2024-05-29 EP disclosed
EP-3563185-B1 POLARIZING ARTICLE AND METHOD OF FORMING A POLARIZING ARTICLE TRANSITIONS OPTICAL LTD (IE) 2024-01-31 EP disclosed
EP-2718754-B1 POLARIZING PHOTOCHROMIC ARTICLES TRANSITIONS OPTICAL INC (US) 2024-01-24 EP disclosed
EP-2895896-B1 A PHOTOCHROMIC ARTICLE HAVING AT LEAST PARTIALLY CROSSED POLARIZED PHOTOCHROMIC-DICHROIC AND FIXED-POLARIZED LAYERS TRANSITIONS OPTICAL INC (US) 2022-11-02 EP disclosed
US-10884288-B2 Polarizing article and method of forming a polarizing article TRANSITIONS OPTICAL, LTD. (IE) 2021-01-05 US disclosed
US-20200103571-A1 Polarizing Article and Method of Forming a Polarizing Article TRANSITIONS OPTICAL, LTD. (IE) 2020-04-02 US disclosed
EP-2895897-B1 A PHOTOCHROMIC ARTICLE HAVING TWO AT LEAST PARTIALLY CROSSED PHOTOCHROMIC-DICHROIC LAYERS TRANSITIONS OPTICAL INC (US) 2020-03-25 EP disclosed
US-10590220-B2 Photoalignment materials having improved adhesion TRANSITIONS OPTICAL, INC. (US) 2020-03-17 US disclosed
US-20170037173-A1 Photoalignment Materials Having Improved Adhesion TRANSITIONS OPTICAL, INC. 2017-02-09 US disclosed
US-9475901-B2 Photoalignment materials having improved adhesion TRANSITIONS OPTICAL, INC. (US) 2016-10-25 US disclosed
WO-2012082299-A1 PHOTOCHROMIC COMPOUNDS AND COMPOSITIONS TRANSITIONS OPTICAL, INC. (US) 2012-06-21 WO disclosed
US-20120120473-A1 POLARIZING PHOTOCHROMIC ARTICLES TRANSITIONS OPTICAL, INC. (US) 2012-05-17 US disclosed
US-20120027960-A1 MESOGENIC STABILIZERS TRANSITIONS OPTICAL, INC. (US) 2012-02-02 US disclosed
US-20120002141-A1 MESOGENIC STABILIZERS TRANSITIONS OPTICAL, INC. (US) 2012-01-05 US disclosed
US-20120003401-A1 MESOGENIC STABILIZERS TRANSITIONS OPTICAL, INC. (US) 2012-01-05 US disclosed
US-20110279883-A1 POLARIZING PHOTOCHROMIC ARTICLES TRANSITIONS OPTICAL, INC. (US) 2011-11-17 US disclosed
US-20110143141-A1 Photochromic compounds and compositions TRANSITIONS OPTICAL, INC. (US) 2011-06-16 US disclosed
WO-2011071794-A1 PHOTOALIGNMENT MATERIALS HAVING IMPROVED ADHESION TRANSITIONS OPTICAL, INC. (US) 2011-06-16 WO disclosed
US-20110135850-A1 PHOTOALIGNMENT MATERIALS HAVING IMPROVED ADHESION TRANSITIONS OPTICAL, INC. (US) 2011-06-09 US disclosed
US-20110129678-A1 Photochromic compounds and compositions TRANSITIONS OPTICAL, INC. (US) 2011-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110143141-A1 Photochromic compounds and compositions CCNA1, CRY1, CCNT1 DNM1 3515/4885MEN1 437/4885KMT2A 563/4885
US-20120027960-A1 MESOGENIC STABILIZERS C1S, PYM1, H1-0 DNM1 1971/4885MEN1 90/4885KMT2A 259/4885
US-20120003401-A1 MESOGENIC STABILIZERS PYM1, BMI1, C1S DNM1 1082/4885MEN1 17/4885KMT2A 375/4885
US-20120002141-A1 MESOGENIC STABILIZERS BMI1, METTL14, PYM1 DNM1 1040/4885MEN1 8/4885KMT2A 293/4885
US-20110129678-A1 Photochromic compounds and compositions CRY2, CRY1, PPOX DNM1 4219/4885MEN1 3110/4885KMT2A 1960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.